. Schematic of the ZnO ALE cycle developed in this work. The Hacac dose and the first argon purge have been repeated n times, with 1 < n < 14 in order to avoid pressurizing of the reaction chamber during the Hacac dose. Saturation was achieved for n = 9 (which adds up to 27 s Hacac dosing). The O2 plasma step follows the repeated Hacac/purge pulses, and the cycle is completed by another purge step. After ALE 12 ± 1 43 ± 1 46 ± 1 Figure S2 . SEM cross-sectional image of the GaP NW substrate, having a 7% Ge-doped Si (Si:Ge) shell, covered with ~60 nm ZnO grown by ALD. The nanowires are ~7.0 µm long and spaced ~1.5 µm apart from each other, and positioned in a regular pseudo-hexagonal pattern. Figure S3 . Low-magnification HAADF-STEM image of the ZnO-covered nanowire also shown in Figure 5 of the manuscript. High-magnification images of seven distinct regions separated by 1 µm along the vertical axis of the nanowire are shown in the middle. Note that the as-deposited ZnO is thinner on top of the gold (Au) nanoparticle used to make the NWs, indicating a nucleation delay for the ALD of ZnO on the Au surface. Yet, the thickness differences before and after ALE are comparable to those measured along the NWs. The consistent difference in ZnO thickness confirms the isotropic character of the ALE process. S-5 Figure S5 . Schematic of possible reaction pathways between Hacac and ZnO as speculated in the manuscript. Pathway 1: upon deprotonation acac -binds in a chelate configuration. The reaction may proceed further with a second Hacac molecule to form volatile Zn(acac)2, resulting in etching. Pathway 2: acac -binds in a bidentate configuration. Reaction pathway 2 creates a stable surface product (pathway 2a) or the acac -can decompose into other surface species (pathway 2b). Both types of surface species of pathway 2 lead to etching inhibition which causes the self-limiting nature of the first half-reaction. The inhibition layer needs to be removed in the second halfreaction (B) to continue the etching reaction.
